The third phase of the 140th China Import and Export Fair, widely known as the Canton Fair, concluded on Nov 4, with businesses from Taizhou reporting strong buyer interest and a significant increase in transactions.
Taizhou Port handled 317 million metric tons of cargo in the first three quarters of this year, up 2.5 percent year-on-year. Container throughput reached 337,000 twenty-foot equivalent units (TEUs), marking a 25.5 percent increase.
Taizhou-based Mabtech Pharmaceutical has secured another overseas regulatory approval for its flagship product, infliximab biosimilar Leiting, in Thailand.
